These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25792600)

  • 1. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
    Roy N; Malik S; Villanueva KE; Urano A; Lu X; Von Figura G; Seeley ES; Dawson DW; Collisson EA; Hebrok M
    Genes Dev; 2015 Mar; 29(6):658-71. PubMed ID: 25792600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.
    Tsuda M; Fukuda A; Roy N; Hiramatsu Y; Leonhardt L; Kakiuchi N; Hoyer K; Ogawa S; Goto N; Ikuta K; Kimura Y; Matsumoto Y; Takada Y; Yoshioka T; Maruno T; Yamaga Y; Kim GE; Akiyama H; Ogawa S; Wright CV; Saur D; Takaori K; Uemoto S; Hebrok M; Chiba T; Seno H
    J Clin Invest; 2018 Aug; 128(8):3475-3489. PubMed ID: 30010625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.
    von Figura G; Fukuda A; Roy N; Liku ME; Morris Iv JP; Kim GE; Russ HA; Firpo MA; Mulvihill SJ; Dawson DW; Ferrer J; Mueller WF; Busch A; Hertel KJ; Hebrok M
    Nat Cell Biol; 2014 Mar; 16(3):255-67. PubMed ID: 24561622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
    Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
    Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice.
    Kimura Y; Fukuda A; Ogawa S; Maruno T; Takada Y; Tsuda M; Hiramatsu Y; Araki O; Nagao M; Yoshikawa T; Ikuta K; Yoshioka T; Wang Z; Akiyama H; Wright CV; Takaori K; Uemoto S; Chiba T; Seno H
    Gastroenterology; 2018 Jul; 155(1):194-209.e2. PubMed ID: 29604291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
    Dal Molin M; Hong SM; Hebbar S; Sharma R; Scrimieri F; de Wilde RF; Mayo SC; Goggins M; Wolfgang CL; Schulick RD; Lin MT; Eshleman JR; Hruban RH; Maitra A; Matthaei H
    Hum Pathol; 2012 Apr; 43(4):585-91. PubMed ID: 21940037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
    Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
    Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.
    Roy N; Takeuchi KK; Ruggeri JM; Bailey P; Chang D; Li J; Leonhardt L; Puri S; Hoffman MT; Gao S; Halbrook CJ; Song Y; Ljungman M; Malik S; Wright CV; Dawson DW; Biankin AV; Hebrok M; Crawford HC
    Genes Dev; 2016 Dec; 30(24):2669-2683. PubMed ID: 28087712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
    Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
    Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
    Layeghi-Ghalehsoukhteh S; Pal Choudhuri S; Ocal O; Zolghadri Y; Pashkov V; Niederstrasser H; Posner BA; Kantheti HS; Azevedo-Pouly AC; Huang H; Girard L; MacDonald RJ; Brekken RA; Wilkie TM
    Sci Rep; 2020 Nov; 10(1):20662. PubMed ID: 33244070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation.
    von Figura G; Morris JP; Wright CV; Hebrok M
    Gut; 2014 Apr; 63(4):656-64. PubMed ID: 23645620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF component
    Wang SC; Nassour I; Xiao S; Zhang S; Luo X; Lee J; Li L; Sun X; Nguyen LH; Chuang JC; Peng L; Daigle S; Shen J; Zhu H
    Gut; 2019 Jul; 68(7):1259-1270. PubMed ID: 30315093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer: A matter of timing.
    Seton-Rogers S
    Nat Rev Cancer; 2015 May; 15(5):256-7. PubMed ID: 25855403
    [No Abstract]   [Full Text] [Related]  

  • 18. ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.
    Wang W; Friedland SC; Guo B; O'Dell MR; Alexander WB; Whitney-Miller CL; Agostini-Vulaj D; Huber AR; Myers JR; Ashton JM; Dunne RF; Steiner LA; Hezel AF
    Gut; 2019 Jul; 68(7):1245-1258. PubMed ID: 30228219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pdx1 expression in pancreatic precursor lesions and neoplasms.
    Park JY; Hong SM; Klimstra DS; Goggins MG; Maitra A; Hruban RH
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):444-9. PubMed ID: 21297446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.